SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '61P'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1Q8J_B_C2FB802_0 (5-METHYLTETRAHYDROFO LATE S-HOMOCYSTEINE METHYLTRANSFERASE)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	5 / 12	GLY A 124 ASP A 219 ILE A 302 GLY A 80 SER A 83	None 61P A 406 (-2.9A) None 61P A 406 (-4.1A) 61P A 406 (-3.0A)	1.19A	1q8jB-5hctA: undetectable	1q8jB-5hctA: 20.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2AOH_C_FRDC305_1 (POL POLYPROTEIN PEPTIDE INHIBITOR)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	4 / 5	LEU A 161 ASP A 307 GLY A 37 ALA A 159	None None 61P A 406 ( 4.0A) None	0.89A	2aohA-5hctA: 7.3	2aohA-5hctA: 12.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CML_A_ZMRA1478_1 (NEURAMINIDASE)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	4 / 7	SER A 113 SER A 83 SER A 115 GLN A 56	None 61P A 406 (-3.0A) None None	1.03A	2cmlA-5hctA: undetectable	2cmlA-5hctA: 20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2CML_D_ZMRD4478_1 (NEURAMINIDASE)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	4 / 8	SER A 113 SER A 83 SER A 115 GLN A 56	None 61P A 406 (-3.0A) None None	0.99A	2cmlD-5hctA: undetectable	2cmlD-5hctA: 20.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V0Z_C_C41C1328_1 (RENIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	6 / 12	ASP A 35 GLY A 37 SER A 38 TYR A 79 ASP A 219 GLY A 221	61P A 406 (-2.7A) 61P A 406 ( 4.0A) None 61P A 406 (-4.3A) 61P A 406 (-2.9A) 61P A 406 ( 4.1A)	0.28A	2v0zC-5hctA: 38.1	2v0zC-5hctA: 24.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V0Z_O_C41O1327_1 (RENIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	5 / 12	ASP A 35 GLY A 37 ASP A 219 GLY A 221 ILE A 302	61P A 406 (-2.7A) 61P A 406 ( 4.0A) 61P A 406 (-2.9A) 61P A 406 ( 4.1A) None	0.66A	2v0zO-5hctA: 37.8	2v0zO-5hctA: 24.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PHA_B_ACRB701_1 (ALPHA-GLUCOSIDASE)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	5 / 12	ASP A 219 ILE A 300 ASP A 119 ILE A 122 ILE A 10	61P A 406 (-2.9A) 61P A 406 (-4.0A) 61P A 406 ( 4.9A) None None	1.30A	3phaB-5hctA: undetectable	3phaB-5hctA: 19.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PRS_A_RITA1001_1 (ENDOTHIAPEPSIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	10 / 10	ILE A 10 ASP A 11 ALA A 16 ILE A 77 TYR A 79 LEU A 125 THR A 135 ILE A 217 THR A 223 ILE A 300	None None None None 61P A 406 (-4.3A) None None None PG4 A 408 (-3.8A) 61P A 406 (-4.0A)	0.25A	3prsA-5hctA: 58.2	3prsA-5hctA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PRS_A_RITA1001_1 (ENDOTHIAPEPSIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	5 / 10	ILE A 77 TYR A 79 LEU A 125 THR A 135 ILE A 302	None 61P A 406 (-4.3A) None None None	0.99A	3prsA-5hctA: 58.2	3prsA-5hctA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PRS_A_RITA1001_2 (ENDOTHIAPEPSIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	10 / 12	ASP A 15 ASP A 33 ASP A 35 GLY A 37 ASP A 119 PHE A 194 ASP A 219 THR A 222 TYR A 226 ILE A 304	PG4 A 408 (-3.7A) 61P A 406 (-4.0A) 61P A 406 (-2.7A) 61P A 406 ( 4.0A) 61P A 406 ( 4.9A) None 61P A 406 (-2.9A) 61P A 406 ( 3.5A) 61P A 406 (-4.0A) None	0.64A	3prsA-5hctA: 58.2	3prsA-5hctA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PRS_A_RITA1001_2 (ENDOTHIAPEPSIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	11 / 12	ASP A 15 ASP A 33 ASP A 35 GLY A 37 GLY A 80 ASP A 81 PHE A 194 ASP A 219 THR A 222 TYR A 226 ILE A 304	PG4 A 408 (-3.7A) 61P A 406 (-4.0A) 61P A 406 (-2.7A) 61P A 406 ( 4.0A) 61P A 406 (-4.1A) 61P A 406 ( 2.8A) None 61P A 406 (-2.9A) 61P A 406 ( 3.5A) 61P A 406 (-4.0A) None	0.34A	3prsA-5hctA: 58.2	3prsA-5hctA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PWW_A_ROCA1001_1 (ENDOTHIAPEPSIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	6 / 12	ASP A 33 ASP A 35 GLY A 80 PHE A 116 LEU A 125 ILE A 217	61P A 406 (-4.0A) 61P A 406 (-2.7A) 61P A 406 (-4.1A) 61P A 406 ( 4.7A) None None	1.19A	3pwwA-5hctA: 57.6	3pwwA-5hctA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PWW_A_ROCA1001_1 (ENDOTHIAPEPSIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	12 / 12	ILE A 10 ASP A 15 ASP A 33 ASP A 35 GLY A 80 PHE A 116 LEU A 125 PHE A 194 ILE A 217 THR A 222 TYR A 226 ILE A 304	None PG4 A 408 (-3.7A) 61P A 406 (-4.0A) 61P A 406 (-2.7A) 61P A 406 (-4.1A) 61P A 406 ( 4.7A) None None None 61P A 406 ( 3.5A) 61P A 406 (-4.0A) None	0.48A	3pwwA-5hctA: 57.6	3pwwA-5hctA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PWW_A_ROCA1001_1 (ENDOTHIAPEPSIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	6 / 12	ILE A 10 ASP A 15 ASP A 33 GLY A 82 PHE A 116 LEU A 125	None PG4 A 408 (-3.7A) 61P A 406 (-4.0A) None 61P A 406 ( 4.7A) None	1.15A	3pwwA-5hctA: 57.6	3pwwA-5hctA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PWW_A_ROCA1001_1 (ENDOTHIAPEPSIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	6 / 12	ILE A 122 GLY A 80 ILE A 217 THR A 222 TYR A 226 ILE A 304	None 61P A 406 (-4.1A) None 61P A 406 ( 3.5A) 61P A 406 (-4.0A) None	1.07A	3pwwA-5hctA: 57.6	3pwwA-5hctA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PWW_A_ROCA1001_2 (ENDOTHIAPEPSIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	7 / 8	GLY A 37 SER A 38 ILE A 77 TYR A 79 SER A 83 ASP A 219 THR A 223	61P A 406 ( 4.0A) None None 61P A 406 (-4.3A) 61P A 406 (-3.0A) 61P A 406 (-2.9A) PG4 A 408 (-3.8A)	0.27A	3pwwA-5hctA: 57.6	3pwwA-5hctA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3PWW_A_ROCA1001_2 (ENDOTHIAPEPSIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	6 / 8	SER A 38 ILE A 77 TYR A 79 ASP A 81 SER A 83 THR A 223	None None 61P A 406 (-4.3A) 61P A 406 ( 2.8A) 61P A 406 (-3.0A) PG4 A 408 (-3.8A)	0.52A	3pwwA-5hctA: 57.6	3pwwA-5hctA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q70_A_RITA2001_1 (CANDIDAPEPSIN-2)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	7 / 12	ASP A 35 GLY A 37 GLY A 80 ASP A 219 THR A 222 TYR A 226 ILE A 304	61P A 406 (-2.7A) 61P A 406 ( 4.0A) 61P A 406 (-4.1A) 61P A 406 (-2.9A) 61P A 406 ( 3.5A) 61P A 406 (-4.0A) None	0.43A	3q70A-5hctA: 11.2	3q70A-5hctA: 26.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q70_A_RITA2001_1 (CANDIDAPEPSIN-2)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	7 / 12	ASP A 35 GLY A 37 ILE A 122 ASP A 219 THR A 222 TYR A 226 ILE A 304	61P A 406 (-2.7A) 61P A 406 ( 4.0A) None 61P A 406 (-2.9A) 61P A 406 ( 3.5A) 61P A 406 (-4.0A) None	1.05A	3q70A-5hctA: 11.2	3q70A-5hctA: 26.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q70_A_RITA2001_2 (CANDIDAPEPSIN-2)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	4 / 6	SER A 38 ILE A 77 TYR A 79 ASP A 119	None None 61P A 406 (-4.3A) 61P A 406 ( 4.9A)	0.71A	3q70A-5hctA: 11.2	3q70A-5hctA: 26.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q70_A_RITA2001_2 (CANDIDAPEPSIN-2)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	4 / 6	SER A 38 ILE A 77 TYR A 79 THR A 223	None None 61P A 406 (-4.3A) PG4 A 408 (-3.8A)	0.23A	3q70A-5hctA: 11.2	3q70A-5hctA: 26.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3Q95_A_ESLA700_1 (ESTROGEN RECEPTOR)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	5 / 12	LEU A 310 ALA A 159 LEU A 325 ILE A 217 GLY A 37	None None None None 61P A 406 ( 4.0A)	1.10A	3q95A-5hctA: undetectable	3q95A-5hctA: 18.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TNE_A_RITA401_1 (SECRETED ASPARTIC PROTEASE)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	10 / 12	ASP A 35 GLY A 37 ILE A 77 GLY A 80 ASP A 81 SER A 83 ASP A 119 ASP A 219 TYR A 226 ILE A 304	61P A 406 (-2.7A) 61P A 406 ( 4.0A) None 61P A 406 (-4.1A) 61P A 406 ( 2.8A) 61P A 406 (-3.0A) 61P A 406 ( 4.9A) 61P A 406 (-2.9A) 61P A 406 (-4.0A) None	0.86A	3tneA-5hctA: 36.7	3tneA-5hctA: 26.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TNE_A_RITA401_2 (SECRETED ASPARTIC PROTEASE)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	4 / 6	SER A 38 TYR A 79 THR A 222 THR A 223	None 61P A 406 (-4.3A) 61P A 406 ( 3.5A) PG4 A 408 (-3.8A)	0.31A	3tneA-5hctA: 36.5	3tneA-5hctA: 26.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TNE_B_RITB401_1 (SECRETED ASPARTIC PROTEASE)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	9 / 12	ASP A 35 GLY A 37 ILE A 77 GLY A 80 ASP A 81 SER A 83 ASP A 119 ASP A 219 ILE A 304	61P A 406 (-2.7A) 61P A 406 ( 4.0A) None 61P A 406 (-4.1A) 61P A 406 ( 2.8A) 61P A 406 (-3.0A) 61P A 406 ( 4.9A) 61P A 406 (-2.9A) None	0.71A	3tneB-5hctA: 36.8	3tneB-5hctA: 26.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3TNE_B_RITB401_2 (SECRETED ASPARTIC PROTEASE)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	5 / 7	SER A 38 TYR A 79 THR A 222 THR A 223 TYR A 226	None 61P A 406 (-4.3A) 61P A 406 ( 3.5A) PG4 A 408 (-3.8A) 61P A 406 (-4.0A)	0.42A	3tneB-5hctA: 36.7	3tneB-5hctA: 26.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ACA_C_DXCC1478_0 (TRANSLATION ELONGATION FACTOR SELB)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	4 / 7	ASP A 35 GLY A 124 ILE A 122 THR A 220	61P A 406 (-2.7A) None None None	0.73A	4acaC-5hctA: undetectable	4acaC-5hctA: 22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R21_A_STRA601_1 (CYTOCHROME P450 FAMILY 17 POLYPEPTIDE 2)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	4 / 6	GLY A 124 SER A 83 ILE A 77 VAL A 112	None 61P A 406 (-3.0A) None None	0.82A	4r21A-5hctA: undetectable	4r21A-5hctA: 21.56
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Y4J_A_LNRA412_1 (ENDOTHIAPEPSIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	7 / 9	ASP A 33 ASP A 35 TYR A 79 ASP A 81 PHE A 116 ASP A 119 LEU A 125	61P A 406 (-4.0A) 61P A 406 (-2.7A) 61P A 406 (-4.3A) 61P A 406 ( 2.8A) 61P A 406 ( 4.7A) 61P A 406 ( 4.9A) None	0.72A	4y4jA-5hctA: 58.6	4y4jA-5hctA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Y4J_A_LNRA412_1 (ENDOTHIAPEPSIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	8 / 9	ASP A 33 ASP A 35 TYR A 79 ASP A 81 SER A 83 SER A 115 PHE A 116 LEU A 125	61P A 406 (-4.0A) 61P A 406 (-2.7A) 61P A 406 (-4.3A) 61P A 406 ( 2.8A) 61P A 406 (-3.0A) None 61P A 406 ( 4.7A) None	0.22A	4y4jA-5hctA: 58.6	4y4jA-5hctA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4Y4J_A_LNRA412_1 (ENDOTHIAPEPSIN)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	6 / 9	ASP A 35 TYR A 79 SER A 83 SER A 113 PHE A 116 LEU A 125	61P A 406 (-2.7A) 61P A 406 (-4.3A) 61P A 406 (-3.0A) None 61P A 406 ( 4.7A) None	1.36A	4y4jA-5hctA: 58.6	4y4jA-5hctA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5O4Y_A_CCSA14_0 (PHE-MAA-ASN-PRO-HIS- LEU-SER-TRP-SER-TRP- 9KK-9KK-ARG-CCS-GLY- NH2)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	4 / 6	PHE A 130 LEU A 128 TRP A 195 GLY A 37	None None None 61P A 406 ( 4.0A)	0.93A	5o4yA-5hctA: undetectable	5o4yA-5hctA: 2.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5O4Y_F_CCSF14_0 (PHE-MAA-ASN-PRO-HIS- LEU-SER-TRP-SER-TRP- 9KK-9KK-ARG-CCS-GLY- NH2)	5hct	ENDOTHIAPEPSIN (Cryphonectria parasitica)	4 / 6	PHE A 130 LEU A 128 TRP A 195 GLY A 37	None None None 61P A 406 ( 4.0A)	1.11A	5o4yF-5hctA: undetectable	5o4yF-5hctA: 2.72

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1Q8J_B_C2FB802_0","5-METHYLTETRAHYDROFOLATE S-HOMOCYSTEINE METHYLTRANSFERASE","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",5,"GLY A 124;ASP A 219;ILE A 302;GLY A  80;SER A  83","None;61P A 406 (-2.9A);None;61P A 406 (-4.1A);61P A 406 (-3.0A)","1.19A","1q8jB-5hctA:undetectable",null],["2AOH_C_FRDC305_1","POL POLYPROTEIN;PEPTIDE INHIBITOR","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",4,"LEU A 161;ASP A 307;GLY A  37;ALA A 159","None;None;61P A 406 ( 4.0A);None","0.89A","2aohA-5hctA:7.3","1q8jB-5hctA:20.66"],["2CML_A_ZMRA1478_1","NEURAMINIDASE","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",4,"SER A 113;SER A  83;SER A 115;GLN A  56","None;61P A 406 (-3.0A);None;None","1.03A","2cmlA-5hctA:undetectable","2aohA-5hctA:12.47"],["2CML_D_ZMRD4478_1","NEURAMINIDASE","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",4,"SER A 113;SER A  83;SER A 115;GLN A  56","None;61P A 406 (-3.0A);None;None","0.99A","2cmlD-5hctA:undetectable","2cmlA-5hctA:20.18"],["2V0Z_C_C41C1328_1","RENIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",6,"ASP A  35;GLY A  37;SER A  38;TYR A  79;ASP A 219;GLY A 221","61P A 406 (-2.7A);61P A 406 ( 4.0A);None;61P A 406 (-4.3A);61P A 406 (-2.9A);61P A 406 ( 4.1A)","0.28A","2v0zC-5hctA:38.1","2cmlD-5hctA:20.18"],["2V0Z_O_C41O1327_1","RENIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",5,"ASP A  35;GLY A  37;ASP A 219;GLY A 221;ILE A 302","61P A 406 (-2.7A);61P A 406 ( 4.0A);61P A 406 (-2.9A);61P A 406 ( 4.1A);None","0.66A","2v0zO-5hctA:37.8","2v0zC-5hctA:24.22"],["3PHA_B_ACRB701_1","ALPHA-GLUCOSIDASE","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",5,"ASP A 219;ILE A 300;ASP A 119;ILE A 122;ILE A  10","61P A 406 (-2.9A);61P A 406 (-4.0A);61P A 406 ( 4.9A);None;None","1.30A","3phaB-5hctA:undetectable","2v0zO-5hctA:24.22"],["3PRS_A_RITA1001_1","ENDOTHIAPEPSIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",10,"ILE A  10;ASP A  11;ALA A  16;ILE A  77;TYR A  79;LEU A 125;THR A 135;ILE A 217;THR A 223;ILE A 300","None;None;None;None;61P A 406 (-4.3A);None;None;None;PG4 A 408 (-3.8A);61P A 406 (-4.0A)","0.25A","3prsA-5hctA:58.2","3phaB-5hctA:19.23"],["3PRS_A_RITA1001_1","ENDOTHIAPEPSIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",5,"ILE A  77;TYR A  79;LEU A 125;THR A 135;ILE A 302","None;61P A 406 (-4.3A);None;None;None","0.99A","3prsA-5hctA:58.2","3prsA-5hctA:100.00"],["3PRS_A_RITA1001_2","ENDOTHIAPEPSIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",10,"ASP A  15;ASP A  33;ASP A  35;GLY A  37;ASP A 119;PHE A 194;ASP A 219;THR A 222;TYR A 226;ILE A 304","PG4 A 408 (-3.7A);61P A 406 (-4.0A);61P A 406 (-2.7A);61P A 406 ( 4.0A);61P A 406 ( 4.9A);None;61P A 406 (-2.9A);61P A 406 ( 3.5A);61P A 406 (-4.0A);None","0.64A","3prsA-5hctA:58.2","3prsA-5hctA:100.00"],["3PRS_A_RITA1001_2","ENDOTHIAPEPSIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",11,"ASP A  15;ASP A  33;ASP A  35;GLY A  37;GLY A  80;ASP A  81;PHE A 194;ASP A 219;THR A 222;TYR A 226;ILE A 304","PG4 A 408 (-3.7A);61P A 406 (-4.0A);61P A 406 (-2.7A);61P A 406 ( 4.0A);61P A 406 (-4.1A);61P A 406 ( 2.8A);None;61P A 406 (-2.9A);61P A 406 ( 3.5A);61P A 406 (-4.0A);None","0.34A","3prsA-5hctA:58.2","3prsA-5hctA:100.00"],["3PWW_A_ROCA1001_1","ENDOTHIAPEPSIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",6,"ASP A  33;ASP A  35;GLY A  80;PHE A 116;LEU A 125;ILE A 217","61P A 406 (-4.0A);61P A 406 (-2.7A);61P A 406 (-4.1A);61P A 406 ( 4.7A);None;None","1.19A","3pwwA-5hctA:57.6","3prsA-5hctA:100.00"],["3PWW_A_ROCA1001_1","ENDOTHIAPEPSIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",12,"ILE A  10;ASP A  15;ASP A  33;ASP A  35;GLY A  80;PHE A 116;LEU A 125;PHE A 194;ILE A 217;THR A 222;TYR A 226;ILE A 304","None;PG4 A 408 (-3.7A);61P A 406 (-4.0A);61P A 406 (-2.7A);61P A 406 (-4.1A);61P A 406 ( 4.7A);None;None;None;61P A 406 ( 3.5A);61P A 406 (-4.0A);None","0.48A","3pwwA-5hctA:57.6","3pwwA-5hctA:100.00"],["3PWW_A_ROCA1001_1","ENDOTHIAPEPSIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",6,"ILE A  10;ASP A  15;ASP A  33;GLY A  82;PHE A 116;LEU A 125","None;PG4 A 408 (-3.7A);61P A 406 (-4.0A);None;61P A 406 ( 4.7A);None","1.15A","3pwwA-5hctA:57.6","3pwwA-5hctA:100.00"],["3PWW_A_ROCA1001_1","ENDOTHIAPEPSIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",6,"ILE A 122;GLY A  80;ILE A 217;THR A 222;TYR A 226;ILE A 304","None;61P A 406 (-4.1A);None;61P A 406 ( 3.5A);61P A 406 (-4.0A);None","1.07A","3pwwA-5hctA:57.6","3pwwA-5hctA:100.00"],["3PWW_A_ROCA1001_2","ENDOTHIAPEPSIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",7,"GLY A  37;SER A  38;ILE A  77;TYR A  79;SER A  83;ASP A 219;THR A 223","61P A 406 ( 4.0A);None;None;61P A 406 (-4.3A);61P A 406 (-3.0A);61P A 406 (-2.9A);PG4 A 408 (-3.8A)","0.27A","3pwwA-5hctA:57.6","3pwwA-5hctA:100.00"],["3PWW_A_ROCA1001_2","ENDOTHIAPEPSIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",6,"SER A  38;ILE A  77;TYR A  79;ASP A  81;SER A  83;THR A 223","None;None;61P A 406 (-4.3A);61P A 406 ( 2.8A);61P A 406 (-3.0A);PG4 A 408 (-3.8A)","0.52A","3pwwA-5hctA:57.6","3pwwA-5hctA:100.00"],["3Q70_A_RITA2001_1","CANDIDAPEPSIN-2","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",7,"ASP A  35;GLY A  37;GLY A  80;ASP A 219;THR A 222;TYR A 226;ILE A 304","61P A 406 (-2.7A);61P A 406 ( 4.0A);61P A 406 (-4.1A);61P A 406 (-2.9A);61P A 406 ( 3.5A);61P A 406 (-4.0A);None","0.43A","3q70A-5hctA:11.2","3pwwA-5hctA:100.00"],["3Q70_A_RITA2001_1","CANDIDAPEPSIN-2","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",7,"ASP A  35;GLY A  37;ILE A 122;ASP A 219;THR A 222;TYR A 226;ILE A 304","61P A 406 (-2.7A);61P A 406 ( 4.0A);None;61P A 406 (-2.9A);61P A 406 ( 3.5A);61P A 406 (-4.0A);None","1.05A","3q70A-5hctA:11.2","3q70A-5hctA:26.62"],["3Q70_A_RITA2001_2","CANDIDAPEPSIN-2","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",4,"SER A  38;ILE A  77;TYR A  79;ASP A 119","None;None;61P A 406 (-4.3A);61P A 406 ( 4.9A)","0.71A","3q70A-5hctA:11.2","3q70A-5hctA:26.62"],["3Q70_A_RITA2001_2","CANDIDAPEPSIN-2","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",4,"SER A  38;ILE A  77;TYR A  79;THR A 223","None;None;61P A 406 (-4.3A);PG4 A 408 (-3.8A)","0.23A","3q70A-5hctA:11.2","3q70A-5hctA:26.62"],["3Q95_A_ESLA700_1","ESTROGEN RECEPTOR","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",5,"LEU A 310;ALA A 159;LEU A 325;ILE A 217;GLY A  37","None;None;None;None;61P A 406 ( 4.0A)","1.10A","3q95A-5hctA:undetectable","3q70A-5hctA:26.62"],["3TNE_A_RITA401_1","SECRETED ASPARTIC PROTEASE","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",10,"ASP A  35;GLY A  37;ILE A  77;GLY A  80;ASP A  81;SER A  83;ASP A 119;ASP A 219;TYR A 226;ILE A 304","61P A 406 (-2.7A);61P A 406 ( 4.0A);None;61P A 406 (-4.1A);61P A 406 ( 2.8A);61P A 406 (-3.0A);61P A 406 ( 4.9A);61P A 406 (-2.9A);61P A 406 (-4.0A);None","0.86A","3tneA-5hctA:36.7","3q95A-5hctA:18.76"],["3TNE_A_RITA401_2","SECRETED ASPARTIC PROTEASE","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",4,"SER A  38;TYR A  79;THR A 222;THR A 223","None;61P A 406 (-4.3A);61P A 406 ( 3.5A);PG4 A 408 (-3.8A)","0.31A","3tneA-5hctA:36.5","3tneA-5hctA:26.44"],["3TNE_B_RITB401_1","SECRETED ASPARTIC PROTEASE","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",9,"ASP A  35;GLY A  37;ILE A  77;GLY A  80;ASP A  81;SER A  83;ASP A 119;ASP A 219;ILE A 304","61P A 406 (-2.7A);61P A 406 ( 4.0A);None;61P A 406 (-4.1A);61P A 406 ( 2.8A);61P A 406 (-3.0A);61P A 406 ( 4.9A);61P A 406 (-2.9A);None","0.71A","3tneB-5hctA:36.8","3tneA-5hctA:26.44"],["3TNE_B_RITB401_2","SECRETED ASPARTIC PROTEASE","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",5,"SER A  38;TYR A  79;THR A 222;THR A 223;TYR A 226","None;61P A 406 (-4.3A);61P A 406 ( 3.5A);PG4 A 408 (-3.8A);61P A 406 (-4.0A)","0.42A","3tneB-5hctA:36.7","3tneB-5hctA:26.44"],["4ACA_C_DXCC1478_0","TRANSLATION ELONGATION FACTOR SELB","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",4,"ASP A  35;GLY A 124;ILE A 122;THR A 220","61P A 406 (-2.7A);None;None;None","0.73A","4acaC-5hctA:undetectable","3tneB-5hctA:26.44"],["4R21_A_STRA601_1","CYTOCHROME P450 FAMILY 17 POLYPEPTIDE 2","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",4,"GLY A 124;SER A  83;ILE A  77;VAL A 112","None;61P A 406 (-3.0A);None;None","0.82A","4r21A-5hctA:undetectable","4acaC-5hctA:22.65"],["4Y4J_A_LNRA412_1","ENDOTHIAPEPSIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",7,"ASP A  33;ASP A  35;TYR A  79;ASP A  81;PHE A 116;ASP A 119;LEU A 125","61P A 406 (-4.0A);61P A 406 (-2.7A);61P A 406 (-4.3A);61P A 406 ( 2.8A);61P A 406 ( 4.7A);61P A 406 ( 4.9A);None","0.72A","4y4jA-5hctA:58.6","4r21A-5hctA:21.56"],["4Y4J_A_LNRA412_1","ENDOTHIAPEPSIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",8,"ASP A  33;ASP A  35;TYR A  79;ASP A  81;SER A  83;SER A 115;PHE A 116;LEU A 125","61P A 406 (-4.0A);61P A 406 (-2.7A);61P A 406 (-4.3A);61P A 406 ( 2.8A);61P A 406 (-3.0A);None;61P A 406 ( 4.7A);None","0.22A","4y4jA-5hctA:58.6","4y4jA-5hctA:100.00"],["4Y4J_A_LNRA412_1","ENDOTHIAPEPSIN","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",6,"ASP A  35;TYR A  79;SER A  83;SER A 113;PHE A 116;LEU A 125","61P A 406 (-2.7A);61P A 406 (-4.3A);61P A 406 (-3.0A);None;61P A 406 ( 4.7A);None","1.36A","4y4jA-5hctA:58.6","4y4jA-5hctA:100.00"],["5O4Y_A_CCSA14_0","PHE-MAA-ASN-PRO-HIS-LEU-SER-TRP-SER-TRP-9KK-9KK-ARG-CCS-GLY-NH2","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",4,"PHE A 130;LEU A 128;TRP A 195;GLY A  37","None;None;None;61P A 406 ( 4.0A)","0.93A","5o4yA-5hctA:undetectable","4y4jA-5hctA:100.00"],["5O4Y_F_CCSF14_0","PHE-MAA-ASN-PRO-HIS-LEU-SER-TRP-SER-TRP-9KK-9KK-ARG-CCS-GLY-NH2","5hct","ENDOTHIAPEPSIN","Cryphonectria parasitica",4,"PHE A 130;LEU A 128;TRP A 195;GLY A  37","None;None;None;61P A 406 ( 4.0A)","1.11A","5o4yF-5hctA:undetectable","5o4yA-5hctA:2.72"]]